Targeted Therapy for BRAF(V600E) Malignant Astrocytoma

PURPOSE: Malignant astrocytomas (MAs) are aggressive central nervous system tumors with poor prognosis. Activating mutation of BRAF (BRAF(V600E)) has been reported in a subset of these tumors, especially in children. We have investigated the incidence of BRAF(V600E) in additional pediatric patient c...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Nicolaides, Theodore P., Li, Huifang, Solomon, David A., Hariono, Sujatmi, Hashizume, Rintaro, Barkovich, Krister, Baker, Suzanne J., Paugh, Barbara S., Jones, Chris, Forshew, Tim, Hindley, Guy F., Hodgson, J. Graeme, Kim, Jung-Sik, Rowitch, David H., Weiss, William A., Waldman, Todd A., James, C. David
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3638050/
https://ncbi.nlm.nih.gov/pubmed/22038996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-1456
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares